Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors*

Journal of Experimental Medicine

Volumn 146, Issue 6, 1977, Pages 1511-1520

  Russell, Stephen W ^a   Doe, William F ^a   McIntosh, Ann Tozier ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; RADIOISOTOPE;

CANCER GROWTH; CANCER REGRESSION; CYTOTOXICITY; IN VITRO STUDY; MACROPHAGE; MICROORGANISM; MOLONEY MURINE SARCOMA ONCOVIRUS; MOUSE; SARCOMA; THEORETICAL STUDY;

CYTOTOXICITY, IMMUNOLOGIC; LIPOPOLYSACCHARIDES; MACROPHAGES; NEOPLASMS, EXPERIMENTAL; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0017670171     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.146.6.1511     Document Type: Article

References (17)

1. Piessens, W. F., W. H. Churchill, Jr., and J. R. David. 1975. Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells. J. Immunol. 114:293.
2. Hibbs, J. B., Jr. 1975. Activated macrophages as cytotoxic effector cells. II. Requirement for local persistence of inducing antigen. Transplantation (Baltimore). 19:81.
3. Alexander, P., and R. Evans. 1971. Endotoxin and double stranded RNA render macrophages cytotoxic. Nat. New Biol. 232:76.
4. Russell, S. W., G. Y. Gillespie, and A. T. McIntosh. 1977. Inflammatory cells in solid murine neoplasms. III. Cytotoxicity mediated in vitro by macrophages recovered from disaggregated regressing Moloney sarcomas. J. Immunol. 118:1574.
5. Evans, R. 1973. Macrophages and the tumour bearing host. Br. J. Cancer. 28(Suppl. 1):19.
6. Van Loveren, H., and W. Den Otter. 1974. Macrophages in solid tumors. I. Immunologically specific effector cells. J. Natl. Cancer Inst. 53:1057.
7. Evans, R. 1976. Tumor macrophages in host immunity to malignancies. In: The Macrophage in Neoplasia. M. A. Fink, editor. Academic Press, Inc., New York. 27.
8. Russell, S. W., and A. T. McIntosh. 1977. Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas. Nature (Lond.). 268:69.
9. Massicot, J. G., W. A. Woods, and M. A. Chirigos. 1971. Cell line derived from a murine sarcoma virus (Moloney pseudotype)-induced tumor: cultural, antigenic, and virological properties. Appl. Microbiol. 22:1119.
10. Todaro, G. J., and S. Baron. 1965. The role of interferon in the inhibition of SV40 transformation of mouse cell line 3T3. Proc. Natl. Acad. Sci. U. S. A. 54:752.
11. Russell, S. W., G. Y. Gillespie, C. B. Hansen, and C. G. Cochrane. 1976. Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of Moloney sarcoma regression or progression. Int. J. Cancer. 18:331.
12. Russell, S. W., W. F. Doe, R. G. Hoskins, and CG. Cochrane. 1976. Inflammatory cells in solid murine neoplasms. I. Tumor disaggregation and identification of constituent inflammatory cells. Int. J. Cancer. 18:322.
13. Gillespie, G. Y., C. B. Hansen, R. G. Hoskins, and S. W. Russell. 1977. Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas. J. Immunol. 119:564.
14. Morrison, D. C., and L. Lieve. 1975. Isolation and characterization of two fractions of lipopolysaccharide from oli. J. Biol. Chem. 250:2911.
15. Cynkin, M. A., and G. Ashwell. 1960. Estimation of 3-deoxysugars by means of the malonaldehyde-thiobarbituric acid reaction. Nature (Lond.). 186:155.
16. Hibbs, J. B., Jr., R. R. Taintor, H. A. Chapman, Jr., and J. Brice Weinberg. 1977. Macrophage tumor killing: influence of the local environment. Science (Wash., D. C). 197:279.
17. Chapman, H. A., Jr., and J. B. Hibbs, Jr. 1977. Modulation of macrophage tumoricidal capability by components of normal serum: a central role for lipid. Science (Wash., D. C). 197:282.